Hot Features
Premium
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Período:
Tipo de Línea:
| Volume | 103,561 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 0.52989 | Mínimo Máximo |
|||||
| Minimo del Dia | 0.49 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Aligos Therapeutics Inc | ALGS | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.0081 | -1.59% | 0.50 | 13:06:42 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.50 | 0.49 | 0.52989 | 0.5081 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 438 | 103,561 | US$ 0.5020708 | US$ 51,995 | - | 0.49 - 1.20 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 13:04:49 | 25 | US$ 0.50 | USD |
Información Financiera Aligos Therapeutics Inc ALGS
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 37.83M | 75.67M | - | 15.53M | -87.68M | -1.16 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Aligos Therapeutics Inc ALGS
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 05/6/2024 | 01:30 | GlobeNewswire Inc. | Aligos Therapeutics Presents Positive Data at the EASL.. |
| 31/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22/5/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Announces Six Abstracts Accepted for.. |
| 22/5/2024 | 15:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/5/2024 | 07:00 | GlobeNewswire Inc. | Aligos Therapeutics Announces the Completion of Enrollment.. |
| 15/5/2024 | 16:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/5/2024 | 15:13 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 07/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/5/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Reports Recent Business Progress.. |
| 30/4/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics to Announce 1st Quarter 2024 Financial.. |
| 25/4/2024 | 15:05 | GlobeNewswire Inc. | Aligos Therapeutics Presents Positive Clinical Data at.. |
| 25/4/2024 | 07:00 | GlobeNewswire Inc. | Aligos Therapeutics Mourns the Passing of MASH Industry.. |
Histórico de Datos ALGS
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5649 | 0.6029 | 0.49 | 0.526583 | 180,706 | -0.0649 | -11.49% |
| 1 Month | 0.66 | 0.7545 | 0.49 | 0.60879 | 275,700 | -0.16 | -24.24% |
| 3 Months | 0.923 | 1.10 | 0.49 | 0.8032293 | 268,321 | -0.423 | -45.83% |
| 6 Months | 0.57 | 1.20 | 0.49 | 0.7967596 | 338,281 | -0.07 | -12.28% |
| 1 Year | 1.12 | 1.20 | 0.49 | 0.7867337 | 237,239 | -0.62 | -55.36% |
| 3 Years | 32.68 | 33.58 | 0.49 | 4.05 | 262,621 | -32.18 | -98.47% |
| 5 Years | 14.74 | 37.5099 | 0.49 | 5.86 | 237,890 | -14.24 | -96.61% |
